| abstract |
The present invention comprises a pharmaceutical composition comprising at least one compound selected from the group consisting of a protein, peptide, oligosaccharide, naturally 5 existing or synthetic compound, a functionally equivalent molecule, and mixtures thereof, which binds to a NLV with the binding specificity of the antigenic determinant of a human histo-blood group antigen, selected from the group consisting of H, A, B, Lea, and Leb antigens. |